Fonar (FONR) Asset Writedowns and Impairment (2010 - 2019)

Fonar (FONR) reported Asset Writedowns and Impairment of -$697000.0 for Q4 2019, up 7.07% quarter-over-quarter from -$750000.0 in Q3 2019.

Fonar (FONR) Asset Writedowns and Impairment (2010 - 2019) Analysis & Trends

Fonar has reported Asset Writedowns and Impairment for 6 years, with the latest figure at -$697000.0 in Q4 2019.

For the quarter ending Q4 2019, Asset Writedowns and Impairment changed N/A year-over-year to -$697000.0; the trailing twelve-month figure through Dec 2019 stood at -$1.0 million (changed N/A YoY), and the FY2013 full-year result was $357500.0, down 65.97% from the prior year.
Asset Writedowns and Impairment for Q4 2019 stood at -$697000.0, up from -$750000.0 in the prior quarter.
The five-year high for Asset Writedowns and Impairment was -$697000.0 in Q4 2019, with the low at -$750000.0 in Q3 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Waters	30,529.42 Bn	30,528.96 Bn	1.11 Bn
2	Thermo Fisher Scientific	183.75 Bn	180.50 Bn	7.74 Bn
3	Danaher	133.13 Bn	127.43 Bn	3.59 Bn
4	Idexx Laboratories	46.14 Bn	45.94 Bn	722.74 Mn
5	Agilent Technologies	38.20 Bn	36.39 Bn	990.00 Mn
6	Natera	31.50 Bn	30.40 Bn	696.04 Mn
7	Iqvia Holdings	31.34 Bn	29.36 Bn	1.36 Bn
8	Illumina	24.51 Bn	23.36 Bn	721.00 Mn
9	Mettler Toledo International	23.53 Bn	23.47 Bn	555.82 Mn
10	Fonar	131.19 Mn	63.30 Mn	21.69 Mn

Download Data